Kolltan proposes IPO

Kolltan Pharmaceuticals Inc., New Haven, Conn. Business: Cancer, Antibodies Date announced: 2014-09-12 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Leerink Partners...